日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses

Cemiplimab治疗局部晚期或转移性继发性血管肉瘤(CEMangio):一项II期临床试验和生物标志物分析

Stefan G van Ravensteijn ,Jacco J de Haan ,Hans Gelderblom ,Maikel J L Nederkoorn ,Melissa H S Hillebrandt-Roeffen ,Mark A J Gorris ,Tessa J J de Bitter ,Annemarie Boleij ,Alem Gusinac ,Thomas H A Ederveen ,Uta E Flucke ,Johannes J Bonenkamp ,Frank M Speetjens ,Suzanne E J Kaal ,Minke Smits ,Kalijn F Bol ,Carla M L van Herpen ,Yvonne M H Versleijen-Jonkers ,Ingrid M E Desar

Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma

探讨转移性黑色素瘤患者中TGF-β通路活性与免疫检查点抑制剂治疗反应之间的关系

van Ravensteijn, Stefan G; Amir, Avital L; Tauriello, Daniele V F; van Herpen, Carla M L; Boers-Sonderen, Marye J; Wesseling, Yvonne J W; van Brussel, Anne G C; Keizer, Diederick M; Verheul, Henk M W; Bol, Kalijn F

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

肠道菌群:调节病毒疫苗和癌症疫苗免疫潜力的新因素

Carrier, Agathe; Manghi, Paolo; Silva, Carolina Alves Costa; Lahmar, Imran; Suissa, Deborah; Iebba, Valerio; Almonte, Andrew A; Ajami, Nadim J; Birebent, Roxanne; Laheurte, Caroline; Schreibelt, Gerty; Lemant, Louis; Fahrner, Jean-Eudes; de Sousa, Eric; Berthier, Franck; Villemonteix, Juliette; Chevalier, Mathieu F; Piccinno, Gianmarco; Hocquet, Didier; Lebhar, Isabelle; Maeurer, Markus; Caillat-Zucman, Sophie; Kobold, Sebastian; Kroemer, Guido; Derosa, Lisa; Launay, Odile; Pieper, Dietmar H; Vital, Marius; Santos-Peral, Antonio; Zaucha, Magdalena; García-Bengoa, María; Thorn-Seshold, Julia; Stirling, Helen; Golden, Encouse; Bol, Kalijn F; White, Michael G; Sahasrabhojane, Pranoti V; Hoballah, Yasmine M; Losh, Jillian S; DePinho, Carolyn R; Dondossola, Eleonora; de Vries, I Jolanda M; Adotevi, Olivier; Wargo, Jennifer A; Rothenfußer, Simon; Segata, Nicola; Formenti, Silvia; Zitvogel, Laurence

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial

辅助性树突状细胞疗法治疗 IIIB/C 期黑色素瘤:MIND-DC 随机 III 期试验

Bol, Kalijn F; Schreibelt, Gerty; Bloemendal, Martine; van Willigen, Wouter W; Hins-de Bree, Simone; de Goede, Anna L; de Boer, Annemiek J; Bos, Kevin J H; Duiveman-de Boer, Tjitske; Olde Nordkamp, Michel A M; van Oorschot, Tom G M; Popelier, Carlijn J; Pots, Jeanne M; Scharenborg, Nicole M; van de Rakt, Mandy W M M; de Ruiter, Valeska; van Meeteren, Wilmy S; van Rossum, Michelle M; Croockewit, Sandra J; Koeneman, Bouke J; Creemers, Jeroen H A; Wortel, Inge M N; Angerer, Caroline; Brüning, Mareke; Petry, Katja; Dzionek, Andrzej; van der Veldt, Astrid A; van Grünhagen, Dirk J; Werner, Johanna E M; Bonenkamp, Johannes J; Haanen, John B A G; Boers-Sonderen, Marye J; Koornstra, Rutger H T; Boomsma, Martijn F; Aarntzen, Erik H J; Gotthardt, Martin; Nagarajah, James; de Witte, Theo J M; Figdor, Carl G; de Wilt, Johannes H W; Textor, Johannes; de Groot, Jan Willem B; Gerritsen, Winald R; de Vries, I Jolanda M

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial

随机辅助树突状细胞MIND-DC试验中,微生物群相关代谢重编程对黑色素瘤患者临床结局的影响

Carolina Alves Costa Silva # ,Gianmarco Piccinno # ,Déborah Suissa # ,Mélanie Bourgin # ,Gerty Schreibelt # ,Sylvère Durand ,Roxanne Birebent ,Marine Fidelle ,Cissé Sow ,Fanny Aprahamian ,Paolo Manghi ,Michal Punčochář ,Francesco Asnicar ,Federica Pinto ,Federica Armanini ,Safae Terrisse ,Bertrand Routy ,Damien Drubay ,Alexander M M Eggermont ,Guido Kroemer ,Nicola Segata ,Laurence Zitvogel ,Lisa Derosa ,Kalijn F Bol ,I Jolanda M de Vries

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib

病例报告:托法替尼挽救了一例免疫抑制剂难治性免疫检查点抑制剂介导的严重结肠炎病例

Mark W D Sweep, Martijn J H Tjan, Mark A J Gorris, Kalijn F Bol, Harm Westdorp

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

临床试验观察:基于树突状细胞(DC)的癌症免疫疗法

Laureano, Raquel S; Sprooten, Jenny; Vanmeerbeerk, Isaure; Borras, Daniel M; Govaerts, Jannes; Naulaerts, Stefan; Berneman, Zwi N; Beuselinck, Benoit; Bol, Kalijn F; Borst, Jannie; Coosemans, An; Datsi, Angeliki; Fučíková, Jitka; Kinget, Lisa; Neyns, Bart; Schreibelt, Gerty; Smits, Evelien; Sorg, Rüdiger V; Spisek, Radek; Thielemans, Kris; Tuyaerts, Sandra; De Vleeschouwer, Steven; de Vries, I Jolanda M; Xiao, Yanling; Garg, Abhishek D

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups

免疫学和基因组学分析揭示血管肉瘤亚组之间具有临床意义的差异

van Ravensteijn, Stefan G; Versleijen-Jonkers, Yvonne M H; Hillebrandt-Roeffen, Melissa H S; Weidema, Marije E; Nederkoorn, Maikel J L; Bol, Kalijn F; Gorris, Mark A J; Verrijp, Kiek; Kroeze, Leonie I; de Bitter, Tessa J J; de Voer, Richarda M; Flucke, Uta E; Desar, Ingrid M E

Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients

III 期黑色素瘤患者对 CD1c+ 髓系和浆细胞样树突状细胞联合辅助疫苗接种的免疫反应

Martine Bloemendal, Kalijn F Bol, Steve Boudewijns, Mark A J Gorris, Johannes H W de Wilt, Sandra A J Croockewit, Michelle M van Rossum, Anna L de Goede, Katja Petry, Rutger H T Koornstra, Carl Figdor, Winald R Gerritsen, Gerty Schreibelt, I Jolanda M de Vries

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

自体单核细胞衍生树突状细胞疫苗联合顺铂治疗 III 期和 IV 期黑色素瘤患者:一项前瞻性、随机 2 期试验

Steve Boudewijns, Martine Bloemendal, Nienke de Haas, Harm Westdorp, Kalijn F Bol, Gerty Schreibelt, Erik H J G Aarntzen, W Joost Lesterhuis, Mark A J Gorris, Alexandra Croockewit, Lieke L van der Woude, Michelle M van Rossum, Marieke Welzen, Anna de Goede, Stanleyson V Hato, Winette T A van der Gra